Investor
ARCH Venture Partners
Chicago · United States
Venture capital firm investing in disruptive science across information technology, life sciences and physical sciences.
Stage
Seed–Series B
Sectors
3 sectors
Cheque
Not confirmed
Invests in
Not confirmed
Sectors
Deep TechB2B SaaSDigital Health
About
This firm provides seed and early stage capital for technology companies. Over three decades, it has supported disruptive science firms with investments ranging from fifty thousand dollars to several hundred million dollars. The team follows scientific discovery to establish companies based on revolutionary technologies. They maintain a long-term view when building businesses, sizing portfolio investments according to specific needs.
Portfolio · 5 · tap a company to read about it
Recent deals
- 2026-06Ollin BiosciencesSeries B
- 2026-06City TherapeuticsSeries B
- 2026-06SonoTheraSeries B
- 2026-01Moonwalk BiosciencesSeries B
- 2025-12SciNeuro PharmaceuticalsGrowthLed
- 2025-11Elephas BiosciencesSeries B
- 2025-01RhyGazeSeries A
- 2024-09Arsenal Biosciences, Inc. (ArsenalBio)Growth
- 2021-11Arbor BiotechnologiesSeries B